
Review ArticleThe Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
Keywords: طراحی آزمایشگاهی بالینی; Alzheimer's disease; Cerebrospinal fluid; Neuroimaging; FDG PET; MRI; Biomarkers; Clinical trial design; Mild cognitive impairment; Cognitive decline;